Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial

BACKGROUND: Biological disease-modifying anti-rheumatic drugs (bDMARDs) are effective in the treatment of rheumatoid arthritis (RA) but are expensive and increase the risk of infection. Therefore, in patients with a stable low level of disease activity or remission, tapering bDMARDs should be consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Messelink, Marianne A., van der Leeuw, Matthijs S., den Broeder, Alfons A., Tekstra, Janneke, van der Goes, Marlies C., Heijstek, Marloes W., Lafeber, Floris, Welsing, Paco M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202120/
https://www.ncbi.nlm.nih.gov/pubmed/35710576
http://dx.doi.org/10.1186/s13063-022-06471-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202120/
https://www.ncbi.nlm.nih.gov/pubmed/35710576
http://dx.doi.org/10.1186/s13063-022-06471-x

Ejemplares similares